Myomo Inc.
MYOMyomo Inc. is a medical robotics company specializing in wearable, powered orthoses designed to assist individuals with arm and hand paralysis due to neurological conditions. The company's flagship product, MyoPro, uses robotic technology to restore some degree of movement and independence to users, primarily serving patients with conditions such as stroke, brachial plexus injury, and spinal cord injury. Founded in 2009 and based in Cambridge, Massachusetts, Myomo focuses on developing innovative neurorehabilitation solutions that enhance quality of life.
Company News
Myomo, Inc. (MYO) delivered earnings and revenue surprises of -40% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income p...
If you are looking for stocks that are well positioned to maintain their recent uptrend, Myomo, Inc. (MYO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Gainers Alset Capital Acquisition Corp. (NASDAQ: ACAX) shares climbed 66.2% to $12.93. YS Biopharma Co., Ltd. (NASDAQ: YS) shares jumped 57% to $1.1850 after the company announced the purchase of shares by company officers. Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 42.1% to $1.7757 after falling over 9% on Thursday. The company, on Th...
Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares gained 57.6% to $1.19 in pre-market trading after the company announced the purchase of shares by company officers. Better Home & Finance Holding Co (NASDAQ: BETR) shares rose 35.6% to $1.56 in pre-market trading after dipping 93% on Thursday. Crown ElectroKinetics Corp. (NASDAQ: CRKN) rose 2...
